The potential of artificial intelligence to bring equity in health care
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
Nearly 1,400 joined the AI for Health Care Equity Conference that explored new AI technologies as a platform for change.
MIT researchers have determined the virus’ protein-coding gene set and analyzed new mutations’ likelihood of helping the virus adapt.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
Prestigious honor society announces more than 250 new members.
Caroline Uhler blends machine learning, statistics, and biology to understand how our bodies respond to illness.
International study reveals gut bacteria from people in industrialized societies swap genes at much higher rates.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
Study suggests forcing bacteria to burn more energy could make them more susceptible to antibiotics.
Analysis reveals genetic control elements that are linked to hundreds of human traits.
Pablo Jarillo-Herrero, Aviv Regev, Susan Solomon, and Feng Zhang are the recipients of distinguished awards for major contributions to science.
Lander to take a leave of absence to assume Cabinet-level post; Zuber to co-chair presidential advisory council.
Using this computational system, researchers can identify viral protein sequences that could make better vaccine targets.
Two MIT faculty members earn funding from the G. Harold and Leila Y. Mathers Foundation.
A diverse group of researchers is working to turn new discoveries about the trillions of microbes in the body into treatments for a range of diseases.
Katie Collins and Marla Odell are heading to the United Kingdom next fall for two years of graduate study.